Ask AI

Precision, Timing, and Teamwork in Melanoma Immunotherapy: Practical Strategies for Resectable and Metastatic Disease

Explore current melanoma immunotherapy strategies for resectable and metastatic disease, including neoadjuvant and adjuvant treatment, pathologic response assessment, individualized neoantigen therapy, and treatment sequencing. Review recent clinical trial evidence, immune-related adverse event management, and multidisciplinary workflows to support personalized care.

Melanoma Immunotherapy

Activity Information

Released: October 29, 2026